BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23426590)

  • 1. Soluble CD40 ligand in morbidly obese patients: effect of body mass index on recovery to normal levels after gastric bypass surgery.
    Baena-Fustegueras JA; Pardina E; Balada E; Ferrer R; Catalán R; Rivero J; Casals I; Lecube A; Fort JM; Vargas V; Peinado-Onsurbe J
    JAMA Surg; 2013 Feb; 148(2):151-6. PubMed ID: 23426590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
    Schernthaner GH; Kopp HP; Krzyzanowska K; Kriwanek S; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 Jun; 36(6):395-401. PubMed ID: 16684123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
    Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-conventional markers of atherosclerosis before and after gastric banding surgery.
    Hanusch-Enserer U; Zorn G; Wojta J; Kopp CW; Prager R; Koenig W; Schillinger M; Roden M; Huber K
    Eur Heart J; 2009 Jun; 30(12):1516-24. PubMed ID: 19380349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: similar body weight loss, correction of comorbidities, and improvement of quality of life.
    Suter M; Calmes JM; Paroz A; Romy S; Giusti V
    Arch Surg; 2009 Apr; 144(4):312-8; discussion 318. PubMed ID: 19380643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halo effect for bariatric surgery: collateral weight loss in patients' family members.
    Woodard GA; Encarnacion B; Peraza J; Hernandez-Boussard T; Morton J
    Arch Surg; 2011 Oct; 146(10):1185-90. PubMed ID: 22006878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the common pathway of coagulation during weight loss induced by gastric bypass in severely obese patients.
    Pardina E; Ferrer R; Rivero J; Baena-Fustegueras JA; Lecube A; Fort JM; Vargas V; Catalán R; Peinado-Onsurbe J
    Obesity (Silver Spring); 2012 May; 20(5):1048-56. PubMed ID: 22193919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: A prospective, comparative analysis.
    Bowne WB; Julliard K; Castro AE; Shah P; Morgenthal CB; Ferzli GS
    Arch Surg; 2006 Jul; 141(7):683-9. PubMed ID: 16847241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
    Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
    Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential loss of fat and lean mass in the morbidly obese after bariatric surgery.
    Zalesin KC; Franklin BA; Lillystone MA; Shamoun T; Krause KR; Chengelis DL; Mucci SJ; Shaheen KW; McCullough PA
    Metab Syndr Relat Disord; 2010 Feb; 8(1):15-20. PubMed ID: 19929598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein intake compliance of morbidly obese patients undergoing bariatric surgery and its effect on weight loss and biochemical parameters.
    Raftopoulos I; Bernstein B; O'Hara K; Ruby JA; Chhatrala R; Carty J
    Surg Obes Relat Dis; 2011; 7(6):733-42. PubMed ID: 21925961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter?
    Bloomston M; Zervos EE; Camps MA; Goode SE; Rosemurgy AS
    Obes Surg; 1997 Oct; 7(5):414-9. PubMed ID: 9730495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese.
    Lin E; Gletsu N; Fugate K; McClusky D; Gu LH; Zhu JL; Ramshaw BJ; Papanicolaou DA; Ziegler TR; Smith CD
    Arch Surg; 2004 Jul; 139(7):780-4. PubMed ID: 15249413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients.
    Vilarrasa N; Vendrell J; Sánchez-Santos R; Broch M; Megia A; Masdevall C; Gomez N; Soler J; Pujol J; Bettónica C; Aranda H; Gómez JM
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):679-86. PubMed ID: 17608757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass.
    Moulin de Moraes CM; Mancini MC; de Melo ME; Figueiredo DA; Villares SM; Rascovski A; Zilberstein B; Halpern A
    Obes Surg; 2005 Oct; 15(9):1287-91. PubMed ID: 16259889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
    Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
    Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic Roux-en-Y gastric bypass: initial 2-year experience.
    Suter M; Giusti V; Héraief E; Zysset F; Calmes JM
    Surg Endosc; 2003 Apr; 17(4):603-9. PubMed ID: 12582767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass.
    Rossi M; Serpa Neto A; Rossi FM; Amarante RD; Alcântara GC; da Silva RB; Regina PF
    Surg Obes Relat Dis; 2009; 5(1):11-8. PubMed ID: 18996755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.